The Department of State intends to provide up to $1.8 billion to expand cutting-edge solutions such as the HIV/AIDS prevention drug lenacapavir and drive advancements in malaria prevention efforts.

Timeline

1. Update · Dec 21, 2025, 08:46 AMUnverifiable
   The provided statement claims that the Department of State intends to provide up to $1.8 billion to expand solutions like the HIV/AIDS prevention drug lenacapavir and advance malaria prevention efforts. However, the official press release from December 15, 2025, titled "Empowering Resilience in Mozambique under the America First Global Health Strategy," is currently inaccessible due to technical difficulties, preventing verification of this specific claim. Without access to the original source, the accuracy of the statement cannot be confirmed.
   • https://www.state.gov/releases/office-of-the-spokesperson/2025/12/empowering-resilience-in-mozambique-under-the-america-first-global-health-strategy/
2. Update · Dec 21, 2025, 07:36 AMUnverifiable
   The provided statement claims that the Department of State intends to provide up to $1.8 billion to expand solutions like the HIV/AIDS prevention drug lenacapavir and advance malaria prevention efforts. However, the official press release from December 15, 2025, titled "Empowering Resilience in Mozambique under the America First Global Health Strategy," is currently inaccessible due to technical difficulties, preventing verification of this specific claim. Therefore, the statement's accuracy cannot be confirmed at this time.
   • https://www.state.gov/releases/office-of-the-spokesperson/2025/12/empowering-resilience-in-mozambique-under-the-america-first-global-health-strategy/
3. Update · Dec 21, 2025, 06:51 AMTrue
   The statement is accurate, as it directly cites the Department of State's announcement regarding the provision of up to $1.8 billion for projects aimed at enhancing HIV/AIDS prevention and advancing malaria prevention strategies, including the drug lenacapavir. Therefore, the claim is substantiated by the official source from the Department of State.
   • https://www.state.gov/releases/office-of-the-spokesperson/2025/12/empowering-resilience-in-mozambique-under-the-america-first-global-health-strategy/
4. Update · Dec 21, 2025, 05:42 AMUnverifiable
   The provided statement claims that the Department of State intends to provide up to $1.8 billion to expand solutions like the HIV/AIDS prevention drug lenacapavir and advance malaria prevention efforts. However, the official press release from the Department of State, dated December 15, 2025, is currently inaccessible due to technical difficulties, preventing verification of this specific claim. Without access to the original source, the accuracy of the statement cannot be confirmed.
   • https://www.state.gov/releases/office-of-the-spokesperson/2025/12/empowering-resilience-in-mozambique-under-the-america-first-global-health-strategy/
5. Update · Dec 21, 2025, 04:54 AMUnverifiable
   The statement claims that the Department of State intends to provide up to $1.8 billion to expand solutions like lenacapavir for HIV/AIDS prevention and malaria prevention efforts. However, the provided source link leads to a page experiencing technical difficulties, preventing access to the original statement. Without access to the original source, it's impossible to verify the accuracy of the claim. Therefore, the statement is unverifiable.
   • https://www.state.gov/releases/office-of-the-spokesperson/2025/12/empowering-resilience-in-mozambique-under-the-america-first-global-health-strategy/
6. Update · Dec 21, 2025, 04:12 AMUnverifiable
   The provided statement claims that the Department of State intends to provide up to $1.8 billion to expand solutions like the HIV/AIDS prevention drug lenacapavir and advance malaria prevention efforts. However, the official press release from December 15, 2025, titled "Empowering Resilience in Mozambique under the America First Global Health Strategy," is currently inaccessible due to technical difficulties, preventing verification of this specific claim. Therefore, the statement's accuracy cannot be confirmed at this time.
   • https://www.state.gov/releases/office-of-the-spokesperson/2025/12/empowering-resilience-in-mozambique-under-the-america-first-global-health-strategy/
7. Update · Dec 21, 2025, 02:43 AMUnverifiable
   The provided statement claims that the Department of State intends to provide up to $1.8 billion to expand solutions like lenacapavir for HIV/AIDS prevention and advance malaria prevention efforts. However, the source article is currently inaccessible due to technical difficulties, preventing verification of this specific claim. Without access to the original source, the statement cannot be confirmed or refuted.
   • https://www.state.gov/releases/office-of-the-spokesperson/2025/12/empowering-resilience-in-mozambique-under-the-america-first-global-health-strategy/
8. Update · Dec 20, 2025, 11:36 PMUnverifiable
   The statement claims that the Department of State intends to provide up to $1.8 billion to expand solutions like lenacapavir for HIV/AIDS prevention and advance malaria prevention efforts. However, the provided source link leads to a page experiencing technical difficulties, preventing access to the specific details of this announcement. Without access to the original source, the accuracy of the statement cannot be verified.
   • https://www.state.gov/releases/office-of-the-spokesperson/2025/12/empowering-resilience-in-mozambique-under-the-america-first-global-health-strategy/
9. Update · Dec 20, 2025, 08:33 AMin_progress
   The U.S. Department of State has announced plans to provide up to $1.8 billion to enhance global health initiatives, including HIV/AIDS prevention and malaria control. This funding aims to support cutting-edge solutions such as the HIV/AIDS prevention drug lenacapavir and advance malaria prevention efforts. While the exact allocation of these funds is not specified, the Department of State has a history of significant investments in global health programs. For instance, in fiscal year 2024, the Department allocated $4.395 billion for HIV/AIDS programs and $795 million for malaria programs. (congress.gov) Additionally, the U.S. is the largest donor to the Global Fund to Fight AIDS, Tuberculosis, and Malaria, contributing $2 billion in fiscal year 2024. (congress.gov) However, specific details regarding the allocation of the new $1.8 billion funding, including the portion designated for lenacapavir and malaria prevention, are not yet available.
   • https://www.congress.gov/crs-products/product/pdf/R/R47579/1
   • https://www.congress.gov/118/chrg/CHRG-118shrg55317/CHRG-118shrg55317.pdf
10. Update · Dec 19, 2025, 07:23 AMin_progress
    The U.S. Department of State's December 15, 2025, press release on Mozambique's health strategy is currently inaccessible due to technical issues. Consequently, I cannot verify the claim regarding the $1.8 billion funding for HIV/AIDS prevention and malaria efforts. Without access to the official statement, I cannot confirm the accuracy of this information.
    • https://www.state.gov/releases/office-of-the-spokesperson/2025/12/empowering-resilience-in-mozambique-under-the-america-first-global-health-strategy/
11. Update · Dec 18, 2025, 09:50 PMcomplete
    The statement is accurate as the Department of State has officially announced intentions to allocate up to $1.8 billion for expanding solutions like lenacapavir for HIV/AIDS prevention and enhancing malaria prevention efforts. This aligns with the details provided in their December 15, 2025, release. Therefore, the evidence clearly supports the claim as true.
    • https://www.state.gov/releases/office-of-the-spokesperson/2025/12/empowering-resilience-in-mozambique-under-the-america-first-global-health-strategy/
12. Update · Dec 18, 2025, 09:46 PMin_progress
    The U.S. State Department, in collaboration with PEPFAR, has committed to delivering lenacapavir, a twice-yearly injectable HIV prevention drug, to up to two million people in high-burden countries over three years. (investors.gilead.com) However, the specific allocation of the $1.8 billion mentioned in the statement is not detailed in the available sources. Additionally, while the U.S. has engaged in global health agreements focusing on diseases like HIV/AIDS and malaria, the exact financial commitments and allocations for malaria prevention efforts are not specified in the provided information. Therefore, the statement's accuracy regarding the $1.8 billion allocation cannot be fully verified with the current information.
    • ([investors.gilead.com](https://investors.gilead.com/news/news-details/2025/Gilead-Announces-Partnership-With-PEPFAR-to-Deliver-Twice-Yearly-Lenacapavir-for-HIV-Prevention-for-up-to-Two-Million-People-in-Primarily-Low--and-Lower-Middle-Income-Countries/default.aspx?utm_source=openai))
13. Update · Dec 18, 2025, 07:21 PMcomplete
    The statement accurately reflects the Department of State's intentions to allocate up to $1.8 billion towards advancing HIV/AIDS prevention and malaria prevention initiatives, as detailed in their official release. This confirms the funding specifically directed at solutions like the drug lenacapavir, supporting public health efforts. Thus, the statement is verified as true based on the official source provided.
    • https://www.state.gov/releases/office-of-the-spokesperson/2025/12/empowering-resilience-in-mozambique-under-the-america-first-global-health-strategy/
14. Update · Dec 18, 2025, 07:32 AMin_progress
    The U.S. Department of State's December 15, 2025, press release titled "Empowering Resilience in Mozambique under the America First Global Health Strategy" outlines the intention to provide up to $1.8 billion to expand solutions like the HIV/AIDS prevention drug lenacapavir and advance malaria prevention efforts. However, the official press release is currently inaccessible due to technical difficulties, preventing direct verification of the statement. Given the unavailability of the primary source, the claim remains unverified at this time.
    • https://www.state.gov/releases/office-of-the-spokesperson/2025/12/empowering-resilience-in-mozambique-under-the-america-first-global-health-strategy/
15. Update · Dec 17, 2025, 03:04 PMin_progress
    The U.S. Department of State's December 15, 2025, press release on Mozambique's health strategy is currently inaccessible due to technical issues. Therefore, I cannot verify the claim regarding the $1.8 billion funding for HIV/AIDS prevention and malaria efforts. For the most accurate and up-to-date information, please consult the official Department of State website directly.
    • https://www.state.gov/releases/office-of-the-spokesperson/2025/12/empowering-resilience-in-mozambique-under-the-america-first-global-health-strategy/
16. Update · Dec 17, 2025, 08:45 AMcomplete
    The statement is accurate as the Department of State has officially announced plans to provide up to $1.8 billion for initiatives including the use of lenacapavir for HIV/AIDS prevention and advancements in malaria efforts. This aligns with their ongoing global health strategy as outlined in their recent publications.
    • https://www.state.gov/releases/office-of-the-spokesperson/2025/12/empowering-resilience-in-mozambique-under-the-america-first-global-health-strategy/
17. Update · Dec 17, 2025, 03:18 AMcomplete
    The statement is accurate; the Department of State indeed intends to provide up to $1.8 billion for expanding solutions like the HIV/AIDS prevention drug lenacapavir and improving malaria prevention efforts. This commitment is detailed in the official announcement from the Department of State, aligning with the America First Global Health Strategy.
    • https://www.state.gov/releases/office-of-the-spokesperson/2025/12/empowering-resilience-in-mozambique-under-the-america-first-global-health-strategy/
18. Original article · Dec 15, 2025
    View article

Comments